By Dawood Fakhir ( June 24, 2026, 3:09 PM BST) -- Thalia Therapeutics said Wednesday that it has agreed to acquire Sanmirna Therapeutics, which specializes in cancer treatments, for up to approximately £16.7 million ($22 million), a move that would transform the British biotech firm into a clinical-stage therapeutics development company....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.